News

Full Year 2025 Results Key Financial Results Revenue: US$292.5m (down 3.8% from FY ...
Fintel reports that on July 16, 2025, Lake Street initiated coverage of AngioDynamics (NasdaqGS:ANGO) with a Buy ...
Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...
Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next ...
A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...
AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...
Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.
An oil field was set on fire after a drone strike in Iraq's Dohuk province, in the Kurdish region. The incident on Tuesday is the latest in a series of ...
Once a powerful watchdog for financial wrongdoing, the Consumer Financial Protection Bureau has seen its enforcement efforts ...
Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...
The Nasdaq Composite ended at 20,585.53, essentially flat on the week (–0.08%), holding just below recent record highs. The ...
Ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to hit the market valuation of US$ 16.74 billion by 2034 at a CAGR of 9.82% during the forecast period 2025–2034. A ...